Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-02 Sale |
2024-01-04 5:16 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
470,000 | $28.13 | $13,222,862 | 120,286 (Indirect Direct) |
View |
| 2023-12-29 Sale |
2024-01-03 4:31 pm |
Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner |
65,803 | $28.04 | $1,845,406 | 32,555,339 (Indirect Direct) |
View |
| 2023-12-27 Sale |
2023-12-29 4:29 pm |
Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner |
251,592 | $28.17 | $7,087,688 | 32,621,142 (Indirect Direct) |
View |
| 2023-12-15 Sale |
2023-12-19 4:30 pm |
Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner |
10,229 | $28.01 | $286,499 | 32,872,734 (Indirect Direct) |
View |
| 2023-12-13 Sale |
2023-12-15 4:31 pm |
Royalty Pharma plc | RPRX | Avara Management Ltd Giuliani Mario Germano 10% Owner |
672,376 | $28.93 | $19,450,288 | 32,882,963 (Indirect Direct) |
View |
| 2023-08-09 Sale |
2023-08-11 5:00 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
75,000 | $30.73 | $2,305,028 | 840,390 (Indirect Direct) |
View |
| 2023-07-12 Sale |
2023-07-14 6:09 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
75,000 | $31 | $2,325,214 | 915,390 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-01 5:46 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,141 | $32.87 | 62,440 (Direct) |
View |
| 2025-03-31 Option Award |
2025-04-01 5:45 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,141 | $32.87 | 114,846 (Direct) |
View |
| 2025-02-14 Conversion |
2025-02-18 5:16 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
330,000 | $0 | 756,641 (Indirect) |
View |
| 2024-12-31 Option Award |
2025-01-02 4:29 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,503 | $24.94 | 61,299 (Direct) |
View |
| 2024-12-31 Option Award |
2025-01-02 4:28 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,503 | $24.94 | 113,705 (Direct) |
View |
| 2024-09-30 Option Award |
2024-09-30 5:08 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,342 | $27.92 | 59,796 (Direct) |
View |
| 2024-09-30 Option Award |
2024-09-30 5:07 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,342 | $27.92 | 112,202 (Direct) |
View |
| 2024-08-12 Gift |
2024-08-12 7:20 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
2,000 | $0 | 349,350 (Indirect) |
View |
| 2024-08-12 Gift |
2024-08-12 7:19 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
7,920 | $0 | 408,232 (Direct) |
View |
| 2024-08-12 Gift |
2024-08-12 7:17 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
2,182 | $0 | 126,412 (Indirect) |
View |
| 2024-06-28 Option Award |
2024-06-28 5:12 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,399 | $26.8 | 110,860 (Direct) |
View |
| 2024-06-28 Option Award |
2024-06-28 5:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,399 | $26.8 | 58,454 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:21 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
9,293 | $0 | 73,738 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:16 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
9,293 | $0 | 46,234 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:15 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
9,293 | $0 | 25,714 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:13 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
9,293 | $0 | 109,461 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:12 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
9,293 | $0 | 43,514 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
9,293 | $0 | 73,738 (Direct) |
View |
| 2024-06-07 Option Award |
2024-06-10 4:09 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
9,293 | $0 | 57,055 (Direct) |
View |
| 2024-05-13 Conversion |
2024-05-16 5:42 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Hite Christopher EVP & Vice Chairman |
330,000 | $0 | 370,541 (Indirect) |
View |
| 2024-03-28 Option Award |
2024-04-02 5:30 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,240 | $30.23 | 100,168 (Direct) |
View |
| 2024-03-28 Option Award |
2024-04-02 5:28 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,240 | $30.23 | 47,762 (Direct) |
View |
| 2024-02-20 Conversion |
2024-02-22 7:23 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
330,000 | $0 | 690,286 (Direct) |
View |
| 2023-12-29 Option Award |
2023-12-29 5:14 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,353 | $27.71 | 98,928 (Direct) |
View |
| 2023-12-29 Option Award |
2023-12-29 5:11 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,353 | $27.71 | 46,522 (Direct) |
View |
| 2023-11-16 Other |
2023-11-16 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
383,000 | $0 | 4,051,170 (Direct) |
View |
| 2022-12-30 Gift |
2023-11-16 5:50 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner |
292,190 | $0 | 4,051,170 (Indirect) |
View |
| 2023-11-13 Conversion |
2023-11-14 7:35 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
165,000 | $0 | 1,412,983 (Indirect) |
View |
| 2023-11-13 Conversion |
2023-11-14 5:17 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
523,149 | $0 | 890,286 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 4:25 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
1,384 | $27.08 | 97,575 (Direct) |
View |
| 2023-09-29 Option Award |
2023-10-03 4:23 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
1,384 | $27.08 | 45,169 (Direct) |
View |
| 2023-08-08 Gift |
2023-08-08 5:39 pm |
N/A N/A |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
6,500 | $0 | 347,559 (Direct) |
View |
| 2023-08-08 Gift |
2023-08-08 5:37 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
1,650 | $0 | 351,350 (Indirect) |
View |
| 2023-08-08 Gift |
2023-08-08 5:36 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & CLO |
5,555 | $0 | 431,152 (Direct) |
View |